Assisted Reproductive Technology Market: Global Industry Analysis, Trends, Drivers, and Forecast until 2021

Renewable energy

 

According to the latest market research study by Technavio, the global ART market is expected to grow at a CAGR of close to 4% during the forecast period 2017 to 2021.

This report by Technavio provides an in-depth analysis of the global ART market in terms of revenue and emerging market trends. The report also includes an up-to-date analysis and forecasts for various market segments and all geographical regions.

Technavio research analysts categorize the market based on the application

Click here to request a free sample of this report

Fertility clinics: Fertility clinics dominated the global ART market owing to the universal increase in the number of fertility centers to meet with the unmet and growing number of fertility patients that has subsequently increased consumption of ART solutions.

“A key factor that would influence the inflow of infertility patients is the high and increase in success rate of the infertility clinics globally. Another major development driving demand for ART procedures is fertility clinics improving their infrastructure to meet the increasing demand from medical tourism for infertility treatment. For instance, organizations such as the ESHRE, ASRM, and ICMART are trying to harmonize fertility tourism and reduce associated exploitations and risks,” says Amber Chourasia, a lead analyst at Technavio for research on health and wellness.

Hospitals: The hospital segment has been growing steadily over the past few years, due to the presence of many hospitals providing ART-related procedures for infertile patients. There are several ART procedures such as in-vitro fertilization, intrauterine insemination (IUI), intracytoplasmic sperm injection, surgical sperm retrieval for ICSI, frozen embryo transfer, and infertility surgery.

Others: The others segment consist of end-users such as research laboratories and cryobanks that provide fertility treatment. Research laboratories can invest in technology, supported by both private and public funding, which allows them to purchase high-end solutions related to fertility. Laboratories provide highly-efficient fertility utilizing controlled microenvironment incubation, non-invasive embryo culture protocols, and continuous time-lapse embryo surveillance technology, which provide effective fertility treatment. Moreover, with the rapid technological advances, there is a change in techniques for freezing sperm and embryos that are well established. Thus, with an increase in funds from public and private sources and continuous technological upgradation, there is steady demand expected from this segment.

Ask an analyst to know more about this report

The top vendors operating in the global assisted reproductive technology market are:

  • Vitrolife
  • Ferring Pharmaceuticals
  • Irvine Scientific
  • Cook Medical

The other prominent vendors in the market include CellCura, EMD Serono, Esco Micro, IKS International (Gonagen Medikal), INVO Bioscience, IVFtech, CRITEX (MedITEX), Pantec Biosolutions, Research Instruments, and Smiths Medical.

A more detailed analysis is available in the Technavio market research report titled, ‘Global ART Market 2017-2021’. Technavio also customizes reports by other regions and specific segments upon request.

Other related reports:

To read more press releases – click here